FB2026_02 , released June 18, 2026
Human Disease Model Report: restless legs syndrome
Open Close
General Information
Name
restless legs syndrome
FlyBase ID
FBhh0000490
Disease Ontology Term
Parent Disease
OMIM
Overview

This report describes general characteristics of the group of diseases classified as restless legs syndrome (RLS). Restless legs syndrome disease is a genetically heterogeneous disorder, with multiple regions defined as susceptibility loci. A list of RLS susceptibility loci, as defined by OMIM, can be found by following the link in the "OMIM phenotypic series" section, below.

[updated Feb. 2017 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: restless legs syndrome
OMIM report
Symptoms and phenotype

Early-onset and late-onset forms of restless legs syndrome have been described. The early-onset form begins before age 45, and sometimes as early as childhood; the and symptoms of this form usually worsen slowly with time. The late-onset form begins after age 45; its symptoms tend to worsen more rapidly. [from Genetics Home Reference; restless legs syndrome; 2017.02.16]

Restless legs syndrome (RLS) is a neurologic disorder characterized by an uncontrollable urge to move the legs during periods of rest. The majority of patients with RLS also have periodic limb movements in sleep, which are characterized by involuntary, highly stereotypical, regularly occurring limb movements (Stefansson et al., 2007; pubmed:17634447). The disorder can result in nocturnal insomnia and chronic sleep deprivation (Bonati et al., 2003; pubmed:12764067). [from MIM:611185, MIM:102300; 2017.01.10]

Genetics

At least 8 regions containing susceptibility loci for restless legs syndrome have been identified; see the associatd phenotypic series. [from MIM:102300; 2017.01.10]

Cellular phenotype and pathology

Iron is involved in several critical activities in brain cells, including the production of dopamine, which is involved in the control of physical movement; it is postulated that malfunction of the dopamine signaling system may underlie the abnormal movements observed with restless legs syndrome. [from Genetics Home Reference; restless legs syndrome; 2017.02.16]

Lower levels of ferritin and higher levels of transferrin in the cerebrospinal fluid (but not in blood serum) have been observed in RLS patients (Earley et al., 2000; pubmed:10762522 and others). [from MIM:102300; 2017.01.10]

Molecular information
External links
Disease synonyms
periodic leg movements
periodic limb movements of sleep
PLMS
RLS
Ortholog Information
Human gene(s) in FlyBase
    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (0)
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (0 groups)
        Alleles Reported to Model Human Disease (Disease Ontology) (0 alleles)
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        References (4)